Comments on "Clinically relevant therapeutic approaches against acetaminophen (APAP) hepatotoxicity and acute liver failure"

Biochem Pharmacol. 2024 May 10:225:116276. doi: 10.1016/j.bcp.2024.116276. Online ahead of print.

Authors

Jan Olof G Karlsson¹, Per Jynge²

Affiliations

¹ Department of Biomedical and Clinical Sciences, Division of Clinical Chemistry and Pharmacology, Linköping University, 581 83 Linköping, Sweden. Electronic address: janolof.karlsson@ktias.com.
² Department of Radiology, Innlandet Trust Hospital, Gjøvik Hospital, 2819 Gjøvik, Norway.

PMID: 38735443
DOI: 10.1016/j.bcp.2024.116276

No abstract available

Keywords: Acetaminophen; Aladote; Calmangafodipir; Clinical trials; Hepatotoxicity; Liver failure.